Department of Medicine

• 
• 
• 
• 

Michael Savona, MD, professor of Medicine and Cancer Biology, and director of Hematology Research at Vanderbilt- Ingram Cancer Center, has received a competitive grant award from the Edward P. Evans Foundation.

The Discovery Research Grant (DRG) will support his work to develop therapies for patients with myelodysplastic syndromes, a group of cancers that occur when immature blood cells in the bone marrow don’t fully develop or fail to become healthy blood cells.

The protein STK17A (serine threonine kinase 17A) appears to play roles in various cancer types.

Using data from the UK Biobank and Vanderbilt’s BioVU, a new study in the journal Molecular Psychiatry finds that approximately 4 percent of suicide attempt risk is captured by genotype data.

About a decade ago, at the beginning of his career in academic medicine, Brian Engelhardt, MD, MSCI, noticed that many of his patients receiving a stem cell transplant for their blood cancer ended up with diabetes.